CBIZ Q2 Earnings Drop 56% as Acquisition Looms; Guidance Pulled
CBZ has more than doubled off its 52-week low of $24.29.
Summary
CBIZ reported a steep 55.6% drop in Q2 net income and withdrew its 2026 guidance, citing the pending acquisition by Grant Thornton. The results were weighed down by integration costs, a legal settlement, and an ESPP correction.
Key Events · Earnings and Guidance · CBZ
-
Q2 Net Income Plunges 55.6%
Net income fell to $19M from $42M a year ago, with GAAP EPS of $0.31 vs. $0.66. Adjusted diluted EPS declined 8.1% to $0.91.
-
Full-Year Guidance Withdrawn
CBIZ suspended its fiscal 2026 outlook and canceled its earnings call, citing the pending acquisition by Grant Thornton.
-
Integration and Legal Costs Weigh on Margins
Q2 included $14.8M in integration costs, a $7.2M legal settlement loss, and a $10.4M ESPP correction expense, compressing margins.
-
First-Half Results Show Modest Growth
First-half net income rose 4.1% to $171M, with GAAP EPS up 9.7% to $2.83, aided by a $58M acquisition-related gain in Q1.
Analysis · CBZ · Trade & Services
A 55.6% plunge in second-quarter net income to $19 million, with GAAP EPS down 53% to $0.31, reflects the weight of higher integration costs, a legal settlement, and an ESPP correction. Adjusted EBITDA also contracted, falling 14.3%. Adding to the uncertainty, management withdrew its full-year 2026 outlook and canceled the earnings call, pointing to the pending $5 billion all-cash acquisition by Grant Thornton. While first-half results managed modest growth, the sharp Q2 deterioration and the suspension of forward guidance underscore near-term operational headwinds ahead of the deal's expected Q4 close.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.3% of the 1324 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CBZ was trading at $54.50 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $24.29 to $77.91. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.